Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2021 Feb;105(2):227-232.
doi: 10.1136/bjophthalmol-2020-315945. Epub 2020 Apr 3.

Visual outcomes after surgery for primary rhegmatogenous retinal detachment in era of microincision vitrectomy: Japan-Retinal Detachment Registry Report IV

Affiliations
Multicenter Study

Visual outcomes after surgery for primary rhegmatogenous retinal detachment in era of microincision vitrectomy: Japan-Retinal Detachment Registry Report IV

Takayuki Baba et al. Br J Ophthalmol. 2021 Feb.

Abstract

Background/aim: To determine the preoperative ocular factors and surgical methods that led to best-corrected visual acuity (BCVA) after pars plana vitrectomy (PPV) or scleral buckling (SB) for rhegmatogenous retinal detachment (RRD).

Methods: This was a prospective, nationwide, multicentre, observational study. Data from the Japanese Retina and Vitreous Society registry from 2016 to 2017 were used to determine the association between preoperative clinical factors, surgical procedures and postoperative BCVA at 6 months. Japanese individuals >40 years of age were included. Eyes with proliferative vitreoretinopathy were included. The primary outcome was the percentage of eyes that achieved 20/25 vision.

Results: Of the 3219 registered cases, 2192 met the inclusion criteria (344 SB, 1738 PPV, 110 PPV+SB). Cases with preoperative BCVA (≤0 logarithm of the minimum angle of resolution (logMAR) units) had good postoperative BCVA (OR=3.97, CI 2.87 to 5.51). Older age (>70 years), low intraocular pressure (<10 mm Hg), high myopia (<-5 dioptres), multiple retinal breaks (>4), giant retinal tear (>90°), wide retinal detachment (>3 quadrants) and macula-off detachment were associated with less probability of postoperative 20/25 vision (OR=0.39, 0.64, 0.62, 0.60, 0.12, 0.51 and 0.36, respectively). Postoperative BCVA was 0.03±0.23 and 0.10±0.32 logMAR units after SB and PPV, respectively. The percentage of cases that achieved 20/25 vision was not significantly different after PPV or SB if cases that had concurrent cataract surgery were excluded (p=0.251).

Conclusions: Better BCVA in patients with RRD who had undergone PPV was observed. However, if concurrent cataract surgery is not performed, BCVA will be comparable with either PPV or SB.

Keywords: retina; treatment surgery; vision.

PubMed Disclaimer

Conflict of interest statement

Competing interests: TB reports personal fees from Bayer Yakuhin, personal fees from Kowa, personal fees from Santen, personal fees from Senju, grants and personal fees from Novartis Pharma KK, personal fees from Alcon Japan, outside the submitted work. RK reports personal fees and other from Topcon, grants and personal fees from Senju, grants and personal fees from Novartis Pharma KK, grants from Pfizer, grants and personal fees from Bayer Yakuhin, personal fees from Roche, personal fees from Takeda, personal fees from Kowa, personal fees from Novo Nordisk, personal fees from Astellas, personal fees from Santen, personal fees from Nitto Medic, personal fees from Office Future, personal fees from Predictive Analytics, personal fees from MICIN, outside the submitted work. KY reports personal fees from Bayer Yakuhin, personal fees from HOYA Corporation, personal fees from Novartis Pharma KK, personal fees from Alcon Japan, personal fees from RE Medical, outside the submitted work. TK reports personal fees from Santen, personal fees from Bayer Yakuhin, personal fees from Novartis Pharma KK, personal fees from HOYA Corporation, personal fees from Ellex, personal fees from Pfizer, personal fees from Kowa, personal fees from Senju, outside the submitted work. KN reports personal fees from Santen, personal fees from RE Medical, personal fees from Carl Zeiss, personal fees from Alcon Japan, personal fees from Novartis Pharma KK, personal fees from Kowa, personal fees from Johnson & Johnson, personal fees from Senju, personal fees from Sanwa Kagaku Kenkyusho, personal fees from HOYA Corporation, outside the submitted work. SY reports grants and personal fees from Santen, grants and personal fees from Jamecs, personal fees from HOYA Corporation, personal fees from Pfizer, personal fees from Senju, personal fees from Alcon Japan, personal fees from Nidek, personal fees from Kowa, personal fees from Bayer Yakuhin, outside the submitted work. TS reports personal fees from Bayer Yakuhin, personal fees from HOYA Corporation, personal fees from Novartis Pharma KK, personal fees from Alcon Japan, personal fees from RE Medical, personal fees from Santen, personal fees from Senju, outside the submitted work.

Similar articles

Cited by

Publication types

MeSH terms

LinkOut - more resources